These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7279809)

  • 21. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
    Samuell CT; Morgans BT; O'Donoghue EP
    Br J Urol; 1984 Apr; 56(2):208-12. PubMed ID: 6498440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
    Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
    Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of immunologic and enzymatic assay of prostatic acid phosphatase for follow-up and assessment of clinical status of stage D prostate cancer.
    El-Shirbiny A; Bhargava A; Beckley S; Fitzpatrick J; Murphy GP
    J Surg Oncol; 1984 Aug; 26(4):256-9. PubMed ID: 6471861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioimmunoassay kit for human prostate acid phosphatase--experimental and clinical evaluation of RIA-Quant P.A.P. Test Kit].
    Wakabayashi K; Sugiyama Y; Takahashi E; Shida K
    Kaku Igaku; 1982 Apr; 19(3):467-75. PubMed ID: 6182321
    [No Abstract]   [Full Text] [Related]  

  • 25. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A solid phase radioimmunoassay for prostatic acid phosphatase.
    Cooper JF; Foti A; Herschman HH; Finkle W
    J Urol; 1978 Mar; 119(3):388-91. PubMed ID: 642096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1985 Jun; 133(6):979-82. PubMed ID: 3999224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
    Br Med J; 1978 Sep; 2(6139):719-20. PubMed ID: 698693
    [No Abstract]   [Full Text] [Related]  

  • 29. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic acid phosphatase: comparison of radioimmunoassay and enzyme activity assay.
    Mensink HJ; Marrink J; Hindriks FR; van Zanten AK
    J Urol; 1983 Jun; 129(6):1136-40. PubMed ID: 6854787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic acid phosphatase - the developing experience.
    Murphy GP; Chu TM; Karr JP
    Clin Biochem; 1979 Dec; 12(6):226-7. PubMed ID: 535156
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
    Salo JO; Rannikko S; Haapiainen R
    Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
    Bruce AW; Mahan DE
    Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
    [No Abstract]   [Full Text] [Related]  

  • 35. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of countercurrent immunoelectrophoretic assay with commercial radioimmunoassay kits for measuring prostatic acid phosphatase.
    Wright GL; Schellhammer PF; Brassil DN; Sieg SM; Leffell MS
    Clin Chem; 1981 Oct; 27(10):1747-52. PubMed ID: 6169470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay of prostatic acid phosphatase: validation and clinical application.
    Franchimont P; Bouffioux C; Reuter A; Rigo-Betz C; Vrindts-Gevaert Y; Jaspar JM; Lecomte-Yerna MJ
    Int J Cancer; 1983 Feb; 31(2):149-55. PubMed ID: 6826245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.